4//SEC Filing
Sylvain Jereme M 4
Accession 0001093557-24-000182
CIK 0001093557other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:12 PM ET
Size
5.3 KB
Accession
0001093557-24-000182
Insider Transaction Report
Form 4
DEXCOM INCDXCM
Sylvain Jereme M
EVP, Chief Financal Officer
Transactions
- Sale
Common Stock
2024-11-15$75.51/sh−3,500$264,285→ 80,774 total
Footnotes (2)
- [F1]On November 21, 2023, Mr. Sylvain adopted a 10b5-1 Plan which was amended on August 6, 2024. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sylvain. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]Included in this number are 49,085 unvested restricted stock units, 26,053 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,060 of which were granted on March 8, 2022 and shall vest through March 8, 2025, and 1,460 of which were granted on December 15, 2021 and shall vest through December 15, 2024.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001681267
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 4:12 PM ET
- Size
- 5.3 KB